Cash Flow from Operating Activities: A company's cash flows from operations.
IDEAYA Biosciences, Inc. (IDYA) had Cash Flow from Operating Activities of $-71.10M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$218.71M |
|
$-113.70M |
|
-- |
|
$218.71M |
|
$378.02M |
|
$-159.31M |
|
$45.62M |
|
$-113.70M |
|
$-113.70M |
|
$-113.70M |
|
$-113.70M |
|
$-113.70M |
|
$-113.70M |
|
$-159.31M |
|
$-164.70M |
|
88.48M |
|
88.48M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$666.73M |
|
$8.22M |
|
$442.60M |
|
$1.11B |
|
$58.81M |
|
-- |
|
$27.57M |
|
$86.39M |
|
$1.02B |
|
$1.02B |
|
$1.02B |
|
87.80M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-71.10M |
$69.98M |
|
$29.78M |
|
$85.18M |
|
$113.84M |
|
$28.66M |
|
$46.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-72.84% |
|
-72.84% |
|
-75.30% |
|
-51.99% |
|
-51.99% |
|
$-73.47M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
-11.11% |
|
-11.11% |
|
-10.25% |
|
-11.11% |
|
$11.65 |
|
$-0.83 |
|
$-0.80 |
|